BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10424019)

  • 21. Haemorheological disturbances in hypertensive type 2 diabetic patients--influence of antihypertensive therapy.
    Kearney-Schwartz A; Virion JM; Stoltz JF; Drouin P; Zannad F
    Fundam Clin Pharmacol; 2007 Aug; 21(4):387-96. PubMed ID: 17635177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of hypertensive patients with diabetes.
    Pahor M; Psaty BM; Furberg CD
    Lancet; 1998 Mar; 351(9104):689-90. PubMed ID: 9504510
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of the fixed-dose combination lercanidipine-enalapril in renal protection.
    Egan CG; Pontremoli R
    J Nephrol; 2011; 24(4):428-37. PubMed ID: 21279953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The morphometric characteristics of the erythrocytes and their catecholamine-binding properties in the treatment of stage-II hypertension patients with Renitec].
    Vizir AD; Ostrovskaia SV
    Lik Sprava; 2000; (5):117-21. PubMed ID: 11031471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal vascular protection: a case for combination antihypertensive therapy.
    Vogel RA
    Prev Cardiol; 2006; 9(1):35-41. PubMed ID: 16407701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individual responses to converting enzyme inhibitors and calcium antagonists.
    Bidiville J; Nussberger J; Waeber G; Porchet M; Waeber B; Brunner HR
    Hypertension; 1988 Feb; 11(2):166-73. PubMed ID: 2830189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study.
    Kjeldsen SE; Westheim AS; Os I
    Lancet; 2000 Dec; 356(9245):1929-30. PubMed ID: 11130406
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan.
    Sakamaki Y; Sasamura H; Ikeda S; Ikegami N; Saruta T
    Hypertens Res; 2006 May; 29(5):333-8. PubMed ID: 16832153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalapril.
    Chatzikyrkou C; Haller H; Menne J
    Expert Opin Pharmacother; 2009 Aug; 10(11):1833-40. PubMed ID: 19527194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neurohumoral changes in patients with mild and moderate forms of hypertension under the influence of losartan].
    Koval' SN; Belovol AN; MiloslavskiÄ­ DK; Masliaeva LV; Mysnichenko OV
    Lik Sprava; 1999 Mar; (2):117-20. PubMed ID: 10424062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A combination of antihypertensives with various mechanisms of action].
    Med Monatsschr Pharm; 2007 Mar; 30(3):120-1. PubMed ID: 17405494
    [No Abstract]   [Full Text] [Related]  

  • 33. [The treatment of mild and moderate arterial hypertension with enalapril. A multicenter study of enap and enap-HL in Russia].
    Ol'binskaia LI
    Ter Arkh; 1997; 69(8):86-8. PubMed ID: 9381405
    [No Abstract]   [Full Text] [Related]  

  • 34. [The activity of the neurohumoral regulatory systems, the status of the electrolyte balance and the clinical efficacy of Renitec in hypertension patients].
    Ol'binskaia LI; Pinskaia EV; Bol'shakova TD; Anastas'ina GV; Tiabenkova VF
    Ter Arkh; 1996; 68(4):54-7. PubMed ID: 9324794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of angiotensin-converting enzyme inhibitors in hypertension].
    Rahn KH
    Z Kardiol; 1988; 77 Suppl 3():69-71. PubMed ID: 2850690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antihypertensive effect of enalapril and lisinopril administered in combination with nonsteroid anti-inflammatory agents].
    Savenkov MP; Ivanov SN; Brodskaia SA
    Ter Arkh; 2001; 73(9):27-31. PubMed ID: 11642076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serial hemodynamic measurements allow better blood pressure control than clinical judgment in those with refractory hypertension.
    Basile J
    J Clin Hypertens (Greenwich); 2002; 4(6):434-5. PubMed ID: 12461310
    [No Abstract]   [Full Text] [Related]  

  • 38. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents.
    Hanselin MR; Saseen JJ; Allen RR; Marrs JC; Nair KV
    Hypertension; 2011 Dec; 58(6):1008-13. PubMed ID: 22042809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacological basis of antihypertensive drug therapy].
    Kolck UW; Zaugg CE; Erne P
    Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.